TWST vs ZBH · rev $332.8M vs P/E 23, rev $4.26B
Twist Bioscience Corp (TWST) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
TWST currently screens at market cap $5.16B. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the TWST and ZBH stock pages for the full models.
Not investment advice.